ProPhase Labs Inc. (PRPH)
OTC PINK OTC PINK Primary 
ProPhase Labs, Inc. (PRPH) Discusses Milestones in Cancer Diagnostics, Genomics Expansion, and COVID Accounts Receivable Collection Transcript
ProPhase Labs, Inc. (PRPH) Discusses Milestones in Cancer Diagnostics, Genomics Expansion, and COVID Accounts Receivable Collection Transcript
ProPhase Labs, Inc. (PRPH) Q2 2025 Earnings Call Transcript
ProPhase Labs, Inc. (NASDAQ:PRPH ) Q2 2025 Earnings Conference Call August 13, 2025 2:00 PM ET Company Participants Ted William Karkus - Chairman & CEO Operator Welcome to today's presentation. My name is Noella Alexander-Young, virtual event moderator here at Renmark Financial Communications.
ProPhase Labs, Inc. (PRPH) Q1 2025 Earnings Call Transcript
ProPhase Labs, Inc. (NASDAQ:PRPH ) Q1 2025 Earnings Conference Call May 20, 2025 10:00 AM ET Company Participants Noella Alexander-Young - Virtual Event Moderator, Renmark Financial Communications Ted Karkus - Chief Executive Officer Noella Alexander-Young Hello, and good morning everyone. Welcome to today's presentation.
ProPhase Labs, Inc. (PRPH) Q4 2024 Earnings Call Transcript
ProPhase Labs, Inc. (NASDAQ:PRPH ) Q4 2024 Earnings Conference Call March 31, 2025 11:00 AM ET Company Participants Noella Alexander-Young - Virtual Event Moderator, Renmark Financial Communications Ted Karkus - Chief Executive Officer Conference Call Participants Noella Alexander-Young Hello and good morning, everyone. Welcome to today's presentation.
Bears are Losing Control Over ProPhase Labs (PRPH), Here's Why It's a 'Buy' Now
ProPhase Labs (PRPH) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
ProPhase Labs, Inc. (PRPH) Q3 2024 Earnings Call Transcript
ProPhase Labs, Inc. (NASDAQ:PRPH ) Q3 2024 Results Conference Call November 13, 2024 11:00 AM ET Company Participants Noella Alexander-Young - Renmark Financial Communications Ted Karkus - Chief Executive Officer Noella Alexander-Young Welcome to today's presentation. My name is Noella Alexander-Young, Virtual Event Moderator here at Renmark Financial Communications.
ProPhase Labs, Inc. (PRPH) Reports Q3 Loss, Tops Revenue Estimates
ProPhase Labs, Inc. (PRPH) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.30 per share a year ago.
ProPhase Labs, Inc. (PRPH) Q2 2024 Earnings Call Transcript
ProPhase Labs, Inc. (NASDAQ:PRPH ) Q2 2024 Earnings Conference Call August 14, 2024 11:00 AM ET Company Participants Noella Alexander-Young - Renmark Financial Communications Ted Karkus - Chief Executive Officer Conference Call Participants Hunter Diamond - Diamond Equity Noella Alexander-Young Hello and good morning, everyone. Welcome to today's presentation.
